Table 4 Immune responses against DTPw-HBV/Hib vaccine antigens 1 month after 3-dose primary vaccination (ATP immunogenicity cohort)
PHiD-CV group | Control group | |||||
|---|---|---|---|---|---|---|
Antigen (cut-off) | N | % (95% CI) | GMC (95% CI) | N | % (95% CI) | GMC (95% CI) |
Diphtheria toxoid (0.1 IU/mL) | 110 | 100 (96.7-100) | 4.103 (3.527-4.773) | 112 | 100 (96.8-100) | 3.130 (2.731-3.588) |
Tetanus toxoid (0.1 IU/mL) | 110 | 100 (96.7-100) | 6.484 (5.511-7.628) | 112 | 100 (96.8-100) | 4.588 (3.880-5.426) |
Bordetella pertussis (15 EL.U/mL) | 110 | 100 (96.7-100) | 111.9 (102.0-122.7) | 111 | 100 (96.7-100) | 124.9 (111.7-139.7) |
HBs (10 mIU/mL) | 91 | 97.8 (92.3-99.7) | 1835.1 (1384.0-2433.2) | 96 | 100 (96.2-100) | 1485.5 (1198.7-1840.9) |
PRP (0.15 μg/mL) | 110 | 100 (96.7-100) | 18.461 (14.256-23.907) | 112 | 99.1 (95.1-100) | 10.137 (7.515-13.673) |